BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 26489581)

  • 1. [A Case of Esophageal Cancer in a Patient with CMV Reactivation after Neoadjuvant Chemoradiation Therapy].
    Megumi K; Okumura H; Shimonosono M; Ijichi T; Uchikado Y; Omoto I; Yo H; Kita Y; Uenosono Y; Arigami T; Mori S; Baba K; Ishigami S; Owaki T; Natsugoe S
    Gan To Kagaku Ryoho; 2015 Oct; 42(10):1307-9. PubMed ID: 26489581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytomegalovirus reactivation during alemtuzumab therapy for chronic lymphocytic leukemia: incidence and treatment with oral ganciclovir.
    Laurenti L; Piccioni P; Cattani P; Cingolani A; Efremov D; Chiusolo P; Tarnani M; Fadda G; Sica S; Leone G
    Haematologica; 2004 Oct; 89(10):1248-52. PubMed ID: 15477211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytomegalovirus reactivation in esophageal cancer patients receiving chemoradiotherapy: A retrospective analysis.
    Kitagawa K; Okada H; Miyazaki S; Funakoshi Y; Sanada Y; Chayahara N; Mayahara H; Fujii M
    Cancer Med; 2021 Nov; 10(21):7525-7533. PubMed ID: 34514723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of cytomegalovirus colitis during chemotherapy for esophageal cancer].
    Kitahara M; Kanekiyo S; Yamamoto T; Watanabe Y; Takeda S; Ueno T; Yoshino S; Hazama S; Oka M
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):2127-9. PubMed ID: 24394035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancytopenia secondary to cytomegalovirus reactivation.
    Tse JR; Ng GX
    BMJ Case Rep; 2014 Jan; 2014():. PubMed ID: 24419641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A Case of Cytomegalovirus Reactivation after Chemoradiotherapy for Esophageal Cancer].
    Adachi S; Niki T; Nishitani N; Horino J; Kawanaka S; Miyazaki Y; Higaki N; Ueshima S; Hayashida H; Ohnishi T; Nezu R
    Gan To Kagaku Ryoho; 2020 Dec; 47(13):1786-1788. PubMed ID: 33468829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initial cytomegalovirus prophylaxis with ganciclovir: no guarantee for prevention of late serious manifestations of CMV after solid organ transplantation.
    Zandberg M; de Maar EF; Hofker HS; Homan van der Heide JJ; Rosati S; van Son WJ
    Neth J Med; 2005 Nov; 63(10):408-12. PubMed ID: 16301763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe esophagitis associated with cytomegalovirus during concurrent chemoradiotherapy for esophageal cancer.
    Aizawa R; Matsumoto S; Uneno Y; Nishikawa Y; Ozaki Y; Mori Y; Kanai M; Ishida Y; Sakanaka K; Hiraoka M; Muto M
    Jpn J Clin Oncol; 2017 Sep; 47(9):885-888. PubMed ID: 28591845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pathological complete response in 2 patients with cT4 esophageal cancer treated with neoadjuvant chemoradiation therapy].
    Takagawa R; Mogaki M; Endo C; Kubo H; Nakayama G; Goto A; Homma Y; Minami Y; Watanabe J; Morita T; Masui H
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):2149-51. PubMed ID: 24394042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytomegalovirus DNAemia and disease: incidence, natural history and management in settings other than allogeneic stem cell transplantation.
    Ng AP; Worth L; Chen L; Seymour JF; Prince HM; Slavin M; Thursky K
    Haematologica; 2005 Dec; 90(12):1672-9. PubMed ID: 16330442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CMV antigenemia (the lower matrix protein PP65), a marker for the guidance of antiviral therapy in cytomegalovirus disease after orthotopic heart transplantation.
    Iberer F; Tscheliessnigg KH; Halwachs G; Auer T; Wasler A; Petutschnigg B; Müller H; Freigassner M; Allmayr T; Hipmair G
    Wien Klin Wochenschr; 1995; 107(23):718-22. PubMed ID: 8560893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytomegalovirus reactivation and preemptive therapy after liver transplant.
    Davoudi S; Kasraianfard A; Ahmadinejad Z; Najafi A; Salimi J; Makarem J; Sohrabpour AA; Jafarian A
    Exp Clin Transplant; 2014 Mar; 12 Suppl 1():72-5. PubMed ID: 24635797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leflunomide failure to control recurrent cytomegalovirus infection in the setting of renal failure after allogeneic stem cell transplantation.
    Battiwalla M; Paplham P; Almyroudis NG; McCarthy A; Abdelhalim A; Elefante A; Smith P; Becker J; McCarthy PL; Segal BH
    Transpl Infect Dis; 2007 Mar; 9(1):28-32. PubMed ID: 17313468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Should recurrent Cytomegalovirus infections in patients with liver transplantation be treated?].
    Tarp BD; Astrup LB
    Ugeskr Laeger; 1997 May; 159(22):3413-6. PubMed ID: 9199030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Symptomatic Cytomegalovirus reactivation related to chemoradiotherapy for adenocarcinoma of lower third esophagus and gastro-esophageal junction cancer.
    Ishi SV; Joshi A; Noronha V; Prabhash K
    Indian J Cancer; 2015; 52(3):280-1. PubMed ID: 26905110
    [No Abstract]   [Full Text] [Related]  

  • 16. Successful treatment of Good syndrome with cytomegalovirus duodenoenteritis using a combination of ganciclovir and immunoglobulin with high anti-cytomegalovirus antibody titer.
    Koriyama N; Fukumoto O; Fukudome M; Aso K; Hagiwara T; Arimura K; Nakazaki M; Arima N; Eizuru Y; Tei C
    Am J Med Sci; 2004 Jan; 327(1):49-54. PubMed ID: 14722398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus-related lymphoproliferative disorder, cytomegalovirus reactivation, and varicella zoster virus encephalitis during treatment of medulloblastoma.
    Ohta M; Taga T; Nomura A; Kato H; Takano T; Maruo Y; Takeuchi Y; Ishida M; Ohta S
    J Med Virol; 2011 Sep; 83(9):1582-4. PubMed ID: 21739449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Impact of initial cytomegalovirus viral load on efficacy of preemptive therapy with ganciclovir in allogeneic stem cell transplant recipients].
    Torre-Cisneros J; Caston-Osorio JJ; Martín C; Rivero A; Doblas A; Rojas R; Gómez P; Martínez F; Torres A
    Enferm Infecc Microbiol Clin; 2010 Jan; 28(1):6-12. PubMed ID: 19409666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring of cytomegalovirus reactivation after allogeneic stem cell transplantation: comparison of an antigenemia assay and quantitative real-time polymerase chain reaction.
    Yakushiji K; Gondo H; Kamezaki K; Shigematsu K; Hayashi S; Kuroiwa M; Taniguchi S; Ohno Y; Takase K; Numata A; Aoki K; Kato K; Nagafuji K; Shimoda K; Okamura T; Kinukawa N; Kasuga N; Sata M; Harada M
    Bone Marrow Transplant; 2002 Apr; 29(7):599-606. PubMed ID: 11979310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Panresistant cytomegalovirus in a kidney transplant recipient.
    Yost SE; Echeverria A; Jie T; Kaplan B
    Pharmacotherapy; 2014 Jan; 34(1):e1-3. PubMed ID: 24277702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.